gene expression analysis
Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.
The company is developing a nonsurgical approach to help increase testing rates and lower the time to diagnosis for endometriosis.
Prostatype Genomics, Life Genomics Ink Commercialization Deal for Prostate Cancer Test
Prostatype's test is designed to use gene expression and certain clinical measures to determine a prostate tumor's aggressiveness and guide treatment.
Resolve Biosciences Raises $71M in Series B Financing
Resolve said it plans to use the proceeds to scale operations and accelerate product development, including a FISH-based spatial transcriptomics method.
The 2020 spinout from UK firm Renalytix is launching an acute rejection risk test, with two other transplant tests expected to launch within the next two years.
Jul 11, 2022
Jun 3, 2022
Vizgen Raises $85.2M in Series C Financing
Apr 25, 2022
Mar 2, 2022
Feb 24, 2022